series-b
Stage
1
Investors
About
Protego Bio develops first-in-class small molecule therapies that restore protein function to treat diseases caused by protein misfolding, including cardiomyopathy and AL amyloidosis.
Explore Protego Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.